Mesoblast (MESO) Other Operating Expenses (2015 - 2025)

Mesoblast's (MESO) quarterly Other Operating Expenses came in at -$618000.0 in Q4 2025, down 163.58% quarter-over-quarter from $972000.0 in Q2 2023.

Mesoblast (MESO) Other Operating Expenses (2015 - 2025) Analysis & Trends

Mesoblast has disclosed Other Operating Expenses across 10 years of filings, most recently posting -$618000.0 for Q4 2025.

  • Other Operating Expenses for Q4 2025 came in at -$618000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$618000.0 (down 163.58% YoY), and the FY2025 annual result was $3.1 million, up 18.79% from the prior year.
  • Other Operating Expenses came in at -$618000.0 for Q4 2025 at Mesoblast, down from $972000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $3.3 million in Q1 2023 to a low of -$618000.0 in Q4 2025.
  • The 4-year median for Other Operating Expenses is $141000.0 (2021), against an average of $367909.1.
  • Across the five-year window, Other Operating Expenses tumbled 471.63% in 2022 and jumped 746.17% in 2023, its largest moves.
  • Mesoblast's Other Operating Expenses stood at -$227000.0 in 2021, then soared by 210.57% to $251000.0 in 2022, then surged by 287.25% to $972000.0 in 2023, then slumped by 163.58% to -$618000.0 in 2025.
  • The last three Other Operating Expenses figures came in at -$618000.0 (Q4 2025), $972000.0 (Q2 2023), and $3.3 million (Q1 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mesoblast 21.68 Bn 21.55 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -618,000.00
Jun 30, 2023 972,000.00
Mar 31, 2023 3.32 Mn
Dec 31, 2022 251,000.00
Sep 30, 2022 -504,000.00
Jun 30, 2022 -524,000.00
Mar 31, 2022 392,000.00
Dec 31, 2021 -227,000.00
Sep 30, 2021 -178,000.00
Jun 30, 2021 141,000.00
Mar 31, 2021 1.03 Mn
Dec 31, 2020 296,000.00
Sep 30, 2020 99,000.00
Jun 30, 2020 391,000.00
Mar 31, 2020 -442,000.00
Dec 31, 2019 143,000.00
Sep 30, 2019 -169,000.00
Jun 30, 2019 -26,000.00
Mar 31, 2019 -82,000.00
Dec 31, 2018 -827,000.00